CCEL Cryo-Cell International, Inc.
Healthcare$3.46+0.58%ClosedMarket Cap: $27.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-1.51
P/S
0.89
EV/EBITDA
-2294.48
DCF Value
$-8.71
FCF Yield
17.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
77.5%
Operating Margin
0.6%
Net Margin
-8.5%
ROE
15.8%
ROA
-4.4%
ROIC
0.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $7.7M | 78.4% | $765.1K | $47.1K | $— | — |
| Q4 null | $7.8M | 77.9% | $-4.0M | $-4.7M | $— | — |
| FY null | $31.6M | 76.6% | $4.8M | $-2.4M | $— | $0.40 |
| Q3 null | $7.8M | 77.0% | $1.9M | $1.6M | $— | — |
| Q2 null | $7.9M | 76.6% | $1.5M | $355.8K | $— | $0.15 |
| Q1 null | $8.0M | 75.1% | $1.1M | $282.9K | $— | $0.25 |
| Q4 null | $8.0M | 79.6% | $-122.3K | $-1.9M | $— | $0.25 |
| FY null | $32.0M | 75.2% | $3.5M | $402.1K | $— | $0.25 |
| Q3 null | $8.1M | 73.6% | $1.4M | $1.1M | $— | — |
| Q2 null | $8.0M | 74.8% | $1.4M | $655.8K | $— | — |
| Q1 2024 | $7.9M | 73.7% | $821.2K | $556.2K | $0.07 | — |
| Q4 2023 | $7.9M | 73.6% | $-16.2M | $-11.2M | $-1.34 | — |